Skip to main content
. 2013 Oct 3;305(11):G818–G828. doi: 10.1152/ajpgi.00106.2013

Table 3.

Levels of specialized proresolving and proinflammation mediators in liver tissue of mice fed PN with SOLE or FOLE

Pathway Marker Transitions
LM, pg/500 mg liver
Quartile 1 Quartile 3 HCD SOLE FOLE
DHA bioactive metabolome
    RvD1 375 215 * * *
    RvD2 375 141 * * *
    RvD3 375 147 * * *
    RvD5 359 199 * * *
    RvD6 359 159 * * *
    PD1 359 153 * * *
    10S,17S-diHDHA 359 153 222 ± 93 173 ± 20 493 ± 217
    10-epi-Δ15-trans-PD1 359 153 38.4 ± 17.5 20.5 ± 0.03 72.7 ± 46.8
    Δ15-trans-PD1 359 153 25.2 ± 11.0 24.4 ± 2.7 68.6 ± 27.3
    22-OH-PD1 375 153 * * *
    22-COOH-PD1 389 153 * * *
    MaR1 359 250 * * *
    7S,14S-diHDHA 359 250 50.3 ± 29.7 49.9 ± 7.1 233 ± 120
    7-epi-Δ12-trans-MaR1 359 250 74.3 ± 35.5 77.8 ± 6.9 136 ± 40
    Δ12-trans-MaR1 359 250 28.7 ± 15.1 46.6 ± 0.3 99.5 ± 24.8
    4S,14S-diHDHA 359 101 80.8 ± 39.1 41.6 ± 16.2 250 ± 101
DHA pathway markers
    17-HDHA 343 245 383 ± 64 243 ± 58 1,006 ± 141§§
    14-HDHA 343 205 2,891 ± 311 2,375 ± 527 6,363 ± 1,300§
    7-HDHA 343 141 47.9 ± 15.2 35.0 ± 3.0 145 ± 32§
    4-HDHA 343 101 124 ± 32 68.0 ± 12.0 309 ± 89
EPA bioactive metabolome
    RvE1 349 195 * * *
    RvE2 333 253 * * *
    RvE3 333 201 * * *
    LXA5 349 215 * * *
    LXB5 349 221 * * *
    5S,15S-diHEPE 333 253 61.0 ± 50.7 30.4 ± 15.2 471 ± 399
EPA pathway markers
    18-HEPE 317 259 35.4 ± 21.6 323 ± 113 4,678 ± 388†††§§§
    15-HEPE 317 219 93.8 ± 54.9 480 ± 157 2,543 ± 152†††§§§
    12-HEPE 317 179 311 ± 151 3,042 ± 691 2,2809 ± 5,514††§
    5-HEPE 317 115 14.8 ± 0.8 59.9 ± 15.5 337 ± 43†††§§§
AA bioactive metabolome
    LXA4 335 115 * * *
    LXB4 351 221 * * *
    5S,15S-diHETE 335 235 96.8 ± 37.3 203 ± 28 162 ± 65
    LTB4 335 195 * * *
    5S,12S-diHETE 335 195 16.3 ± 5.1 19.1 ± 4.5 69.9 ± 34.6
    12epi-Δ6-trans-LTB4 335 195 11.1 ± 5.0 8.0 ± 1.0 2.6 ± 1.3
    Δ6-trans-LTB4 335 195 13.3 ± 5.2 10.9 ± 0.4 3.3 ± 1.6
    20-OH-LTB4 351 195 * * *
    20-COOH-LTB4 365 195 * * *
    PGD2 351 189 770 ± 489 792 ± 168 198 ± 72
    PGE2 351 189 525 ± 393 197 ± 16 123 ± 56
    PGF2α 353 193 925 ± 413 1,731 ± 668 283 ± 105
    TXB2 369 169 60.8 ± 45.8 24.6 ± 5.6 17.2 ± 6.3
AA pathway markers
    15-HETE 319 219 681 ± 135 1,383 ± 374 792 ± 85
    12-HETE 319 179 3,325 ± 374 5,051 ± 769 3,302 ± 246
    5-HETE 319 115 138 ± 29 113 ± 10 52.4 ± 3.7
Sum of proresolving mediators 677 ± 250 667 ± 19 1,984 ± 1,040
Sum of proinflammatory mediators 2,261 ± 1,130 2,758 ± 831 680 ± 253
Proresolution index 0.3 0.2 2.9
(sum of proresolving mediators/sum of inflammatory mediators)

LM values are means ± SE (n = 3). Quartile 1, M-H (parent ion); quartile 3, diagnostic ions in the MS-MS (daughter ion).

*

Below limits of detection (detection limit was ∼2 pg in tissue matrix). Ion suppression effect was 85–92%.

P < 0.05,

††

P < 0.01,

†††

P < 0.001 vs. HCD.

§

P < 0.05,

§§

P < 0.01,

§§§

P < 0.001 vs. SOLE.